Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1995-05-25
1997-08-12
Knode, Marian C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 691, 4351723, 43525231, 43525233, 43525411, 435325, 435348, 435419, 536 2372, 536 231, C12P 2100, C12N 1511, C12N 1538
Patent
active
056564570
ABSTRACT:
Disclosed are recombinant, synthetically and otherwise biologically produced novel proteins and polypeptides which are encoded by the DNA sequence for HSV-2 glycoprotein G (gG) or fragments of said gG sequence, particularly by the unique sequence for gG or portions of said unique sequence. The unique sequence proteins and polypeptides are serologically active, can be produced easily and safely at low cost, are useful as diagnostic reagents for HSV-2 and as vaccines against HSV-2. Further disclosed are serological assays based on such unique sequence gG proteins and polypeptides that diagnose the presence of herpes simplex virus type 2 (HSV-2) specific antibodies and can differentiate between HSV-2 and herpes simplex virus type 1 (HSV-1) specific antibodies. Such assays are useful to diagnose genital infections, to detect for exposure to HSV-2 and to screen pregnant women to protect newborns from neonatal HSV-2 infection. Also disclosed are antibodies to such gG proteins and polypeptides which are useful therapeutically, diagnostically and for affinity purification. Further, disclosed are purified and isolated DNA molecules which can be used as probes specific for HSV-2 DNA.
REFERENCES:
patent: 4452901 (1984-06-01), Gordon et al.
patent: 4618578 (1986-10-01), Burke et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4709011 (1987-11-01), Cohen et al.
patent: 4745182 (1988-05-01), Cohen et al.
patent: 4761470 (1988-08-01), Emini et al.
patent: 4762708 (1988-08-01), Cohen et al.
patent: 4764459 (1988-08-01), Hampar et al.
patent: 4855224 (1989-08-01), Berman et al.
patent: 5124255 (1992-06-01), Bolling et al.
McGeoch et al. J. Gen. Virol. (1987) 68, 19-38.
Alexander and Elder, "Carbohydrate Dramatically Influences Immune Reactivity of Antisera to Viral Glycoprotein Antigens," Science, 226 (4680): 1328-1330 (Dec. 14, 1984).
Ashley et al., "Comparison of Western Blot (Immunoblot) and Glycoprotein G-Specific Immunodot Enzyme Assay for Detecting Antibodies to Herpes Simplex Virus Types 1 and 2 in Human Sera," J. Clin. Microbiol., 26 (4): 662-667 (Apr. 1988).
Balachandran and Hutt-Fletcher, "Synthesis and Processing of Glycoprotein gG of Herpes Simplex Virus Type 2," J. Virol., 44: 344-355 (1982).
Berman et al., "Detection of Antibodies to Herpes Simplex Virus with a Continuous Cell Line Expressing Cloned Glycoprotein D," Science, 222: 524-527 (Nov. 4, 1983).
Caust et al., "Glycosylation, an important modifier of rotavirus antigenicity," Arch. Virol., 96 (3-4): 123-124 (1987).
Corey et al., "Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications," Ann. Int. Med., 98: 958-972 (1983).
Douglas, "DNA Viruses: Herpetoviridae", pp. 944-951 in Principles and Practice of Infectious Diseases (2d ed.) (Mandrell et al. eds) (1985).
Glorioso et al., "Inhibition of Glycosylation of Herpes Simplex Virus Glycoproteins: Identification of Antigenic and Immunogenic Partially Glycosylated Glycopeptides on the Cell Surface Membrane," Virol. 126 (1): 1-18 (Apr. 15, 1983).
Hongo et al., "Effects of glycosylation on the conformation and antigenicity of influenza C viral glycoproteins," Vaccine, 3 (3 suppl.): 223-226 (Sep. 1985).
Lee et al., "Detection of Herpes Simplex Virus Type 2-Specific Antibody with Glycoprotein G," J. Clin. Microbiol., 22 (4): 641-644 (Oct. 1985).
Marsden et al., "Characterization of the 92,000-Dalton Glycoprotein Induced by Herpes Simplex Virus Type 2," J. Virol., 50 (2): 547-554 (May 1984).
McGeoch et al., "DNA Sequence and Genetic Content of the HindIII l Region in the Short Unique Component of the Herpes Simplex Virus Type 2 Genome: Identification of the Gene Encoding Glycoprotein G, and Evolutionary Comparisons," J. Gen. Virol., 68: 19-38 (1987).
Plummer, "A Review of the Identification and Titration of Antibodies to Herpes Simplex Viruses Type 1 and 2 in Human Sera," Cancer Res., 33: 1469-1476 (Jun. 1973).
Roizman et al., "Identification and Preliminary Mapping with Monoclonal Antibodies of a Herpes Simplex Virus 2 Glycoprotein Lacking a Known Type 1 Counterpart," Virol., 133: 242-247 (1984).
Serafini-Cessi et al., "Oligosaccharide Chains of Herpes Simplex Virus Type 2 Glycoprotein gG.2," Archives Biochem. Biophys., 240 (2): 866-876 (Aug. 1, 1985).
Su and Courtney, "Inducible Expression of Herpes Simplex Virus Type 2 Glycoprotein Gene gG-2 in a Mammalian Cell Line," J. Virol., 62 (10): 3668-3674 (Oct. 1988).
Sugawara et al., "Operational and Topological Analyses of Antigenic Sites on Influenza C Virus Glycoprotein and Their Dependance on Glycosylation," J. Gen. Virol., 69: 537-547 (1988).
Sullender et al., "Type-Specific Antibodies to Herpes Simplex Virus Type 2 (HSV-2) Glycoprotein G in Pregnant Women, Infants Exposed to Maternal HSV-2 Infection at Delivery, and Infants with Neonatal Herpes," J. Infect. Diseases, 157(1): 164-171 (Jan. 1988).
Watson et al., "Herpes Simplex Virus Type-1 Glycoprotein D Gene: Nucleotide Sequence and Expression in Escherichia coli,"Science, 218: 381-384 (Oct. 22, 1982).
Weis et al., "An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D," Nature, 302: 72-74 (Mar. 1983).
Whittaker, "Herpelisa II Test Kit (192 Tests), An Enzyme-Linked Immunosorbent Assay for Herpesvirus IgG (Type 1 and 2) Antibody in Human Serum," Whittaker Bioproducts Brochure P3134 (May 1988).
Wilcox et al., "The Contribution of Cysteine Residues to Antigenicity and Extent of Processing of Herpes Simplex Virus Type 1 Glycoprotein D," J. Virol., 62 (8): 1941-1947 (Jun. 1988).
Coates Stephen Ralph
Parkes Deborah Lynn
Blackburn Robert P.
CIBA Corning Diagnostics Corporation
Knode Marian C.
McClung Barbara G.
Robins Roberta L.
LandOfFree
DNA sequence for the unique sequence herpes simplex virus type 2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA sequence for the unique sequence herpes simplex virus type 2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA sequence for the unique sequence herpes simplex virus type 2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-159441